CHRN is a weak-quality, momentum-failing name with no clear engine edge; the risk case dominates and the position is flagged for exit rather than accumulation.
Thesis pillars
- Quality Below Floor→Stable
- Momentum Gate Failure→Stable
- No Clear Engine Edge→Stable
- +1 more pillar — see the Why tab for full reasoning
ChronoScale Holdings Corporatio (CHRN) Stock Analysis
Oversold Bounce setup
Technology · Information Technology Services
Sell if holding. Engine safety override at $16.31: Quality below floor (1.3 < 4.0) triggers a hard block regardless of the otherwise-positive setup — overall score 3.9/10 and A.R:R 4.5:1 is above the 1.5:1 BUY gate. Specifically: Below-average business quality; Rich valuation.
ChronoScale Corporation (formerly Chron Organization) is a Nevada company that has agreed to a business combination in which a contributor is expected to own about 97% of the combined company's equity. It is positioned around data center and compute infrastructure after the... Read more
Sell if holding. Engine safety override at $16.31: Quality below floor (1.3 < 4.0) triggers a hard block regardless of the otherwise-positive setup — overall score 3.9/10 and A.R:R 4.5:1 is above the 1.5:1 BUY gate. Specifically: Below-average business quality; Rich valuation. Chart setup: Oversold RSI 27, near Bollinger lower, volume surge. Score 3.9/10, high confidence.
Passes 6/8 gates (favorable risk/reward ratio, clean insider activity, news events none recent, earnings proximity no date, semi cycle peak clear, materials cycle peak clear). Fails on weak momentum. Suitability: speculative.
About ChronoScale Holdings Corporatio
About ChronoScale Corporation
Ekso Bionics generated most of its revenue from Enterprise Health sales of the EksoNR and Ekso Indego Therapy rehabilitation exoskeletons to inpatient rehabilitation facilities, while its Personal Health segment sold the Ekso Indego Personal device to individuals, aided by an April 2024 CMS Medicare reimbursement determination of approximately $91,000 per device. As of December 31, 2025, an estimated 309,000 people were living with spinal cord injury in the U.S. The company had signed distribution agreements with National Seating & Mobility, Bionic Prosthetics & Orthotics Group, and Ottobock Patient Care to expand reimbursement volume.
In its Enterprise Health market, Ekso Bionics sold EksoNR and Ekso Indego Therapy devices to rehabilitation facilities - primarily larger integrated delivery networks - either as outright capital sales or through 12-to-36-month subscription arrangements financed by third-party partners, layering on the EksoCare extended-warranty and clinical-support program and multi-year training packages; sales cycles ran eight to twelve months for a facility's first device. The company also sold the Ekso EVO upper-body exoskeleton to industrial customers in aerospace, automotive, and manufacturing to reduce worker fatigue and injury. In Personal Health, Ekso Indego Personal reached individual users with spinal cord injuries through Durable Medical Equipment suppliers who pursued Medicare, Medicaid, VA, or workers'-compensation reimbursement on the patient's behalf, plus self-pay and private-insurance channels; the VA, with 25 SCI centers, represented the largest single network of SCI care Ekso Bionics served. The company intended to shift a significant share of manufacturing to third-party contractors to reduce costs, though it had no long-term manufacturing or supply agreements in place.
Show full overview
The clearest signal in this filing is a structural discontinuity between the business described above and the company's near-term future: on May 5, 2026, Ekso Bionics closed a Contribution and Exchange Agreement with Applied Digital Corporation, becoming ChronoScale Corporation with Applied Digital's Contributor entity holding approximately 97% of combined equity, and on May 29, 2026 the renamed company's board committed to divesting the entire legacy Ekso Bionics exoskeleton business to focus solely on Applied Digital Cloud's data-center operations. In other words, the rehabilitation-robotics business this 10-K describes in detail is the business ChronoScale has since decided to exit - a reader relying on Item 1 alone would be evaluating a company that, within months of the filing, stopped being that company.
See also: Technology · Information Technology Services
From ChronoScale Corporation's most recent 10-K filing, extracted October 11, 2026.
Recent developments
updated 2026-10-14Recent Developments — ChronoScale Holdings Corporatio
Latest news
- NEWS ChronoScale Expands AI Pipeline With $1 Billion Revenue Run Rate In Sight — benzinga Oct 2, 2026 positive
- NEWS Reported Earlier, ChronoScale Holdings Subsidiary Sells Ekso Bionics To Wandercraft In Simultaneously Signed And Closed — benzinga Oct 2, 2026 neutral
- NEWS ChronoScale Signs Contract Extension And New Agreement With AI Infrastructure Customers; Agreements Provide For $1B Annu — benzinga Oct 1, 2026 positive
- NEWS Northland Capital Markets Initiates Coverage On ChronoScale Holdings with Outperform Rating, Announces Price Target of $ — benzinga Sep 18, 2026 positive
- NEWS ChronoScale Announces Plans With Microsoft For 50-MW AI Compute Deployment In North America — benzinga Aug 27, 2026 positive
Generated 2026-10-14T11:57:17Z.
Upcoming dated catalysts
Thesis
Key Metrics
Quality Signals
Material Events(8-K, last 90d)
- 2026-06-30Item 5.02LOWOn June 29, 2026 the Board grew from seven to eight members and appointed Andrew Cordell Schaap, who joined the Audit Committee (replacing Douglas Miller, who stays on the Board) and the Related Party Transactions Committee, with a 200,000-share restricted stock award. His company is party to a data center lease with a subsidiary.SEC filing →
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.
Show full disclosure ▾Hide full disclosure ▴
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
Rating Breakdown
3 floor-breakers
Priced at a premium — multiples above sector norms. Needs delivery on growth + margins to justify.static
Unprofitable operations — net margin -70.3%. Quality floor flags this regardless of sector context.static
Ranks in the bottom of its industry peers on the composite signal. Better names in the same sector exist.static
Price Targets
Position Sizing
Risk Alerts
Earnings
Verdict History
Frequently Asked Questions
Sell if holding. Engine safety override at $16.31: Quality below floor (1.3 < 4.0) triggers a hard block regardless of the otherwise-positive setup — overall score 3.9/10 and A.R:R 4.5:1 is above the 1.5:1 BUY gate. Specifically: Below-average business quality; Rich valuation. Chart setup: Oversold RSI 27, near Bollinger lower, volume surge. Prior stop was $15.17. Score 3.9/10, high confidence.
Take-profit target: $27.20 (+66.8% upside). Prior stop was $15.17. Stop-loss: $15.17.
Quality below floor (1.3 < 4.0).
ChronoScale Holdings Corporatio trades at a P/E of N/A (forward -81.3). TrendMatrix value score: 0.0/10. Verdict: Sell.
8 analysts cover CHRN with a consensus score of 4.0/5. Average price target: $32.
What does ChronoScale Holdings Corporatio do?ChronoScale Corporation (formerly Chron Organization) is a Nevada company that has agreed to a business combination in...
ChronoScale Corporation (formerly Chron Organization) is a Nevada company that has agreed to a business combination in which a contributor is expected to own about 97% of the combined company's equity. It is positioned around data center and compute infrastructure after the transaction.